Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Business & Finance

Essure maker reports 82% Q2 sales growth over prior year

Highlights of the company's recent progress in marketing the Essure system include:

1) U.S. Food and Drug Administration approved 4- and 5-year effectiveness rating for the Essure device that is comparable to the 3-year rating;

2) UnitedHealthcare provided favorable reimbursement coverage decision;

3) Common procedural terminology code and fee schedule loaded to payment systems of approximately 70% of payers;

4) Six Medicaid programs...

• View Other Issues of Women's Health Weekly
  
• View Other NewsRx Publications